U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189301189301Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNo Results AvailableAmyotrophic Lateral SclerosisDrug: TCH346https://ClinicalTrials.gov/show/NCT00072709
189302189302“SALT Trial” Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNo Results AvailableHyponatremias|Water Intoxication|Inappropriate ADH Syndrome|Water-Electrolyte ImbalancesDrug: tolvaptanhttps://ClinicalTrials.gov/show/NCT00072683
189303189303A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate CancerCompletedNo Results AvailableProstate CancerDrug: Trabectedinhttps://ClinicalTrials.gov/show/NCT00072670
189304189304Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBehavioral: Cognitive Behavioral Therapy|Behavioral: Tai Chi Chih|Behavioral: Health Education Seminarhttps://ClinicalTrials.gov/show/NCT00072657
189305189305Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-Infected Patients Receiving Single-Dose PrednisoneCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00072644
189306189306Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableAdvanced Non Small Cell Lung Cancer|Failed Prior ChemotherapyDrug: Tarceva (Trademark) (erlotinib HCl, OSI-774)https://ClinicalTrials.gov/show/NCT00072631
189307189307Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNo Results AvailableNSCLCDrug: Exisulindhttps://ClinicalTrials.gov/show/NCT00072618
189308189308Experimental Ebola Vaccine TrialCompletedNo Results AvailableHemorrhagic Fever, Ebola|HealthyDrug: VRC-EBODNA012-00-VPhttps://ClinicalTrials.gov/show/NCT00072605
189309189309An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard TherapiesCompletedNo Results AvailableWegener's GranulomatosisDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00072592
189310189310Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial TreatmentCompletedNo Results AvailableLeukemiaBiological: sargramostimhttps://ClinicalTrials.gov/show/NCT00072579
189311189311Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedHas ResultsPrimary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage IV Ovarian CancerBiological: Bevacizumab|Drug: Cyclophosphamide|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00072566
189312189312Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal CancerDrug: celecoxib|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatin|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00072553
189313189313S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the CervixWithdrawnNo Results AvailableStage 0 Cervical Cancer|High-grade Squamous Intraepithelial LesionDrug: celecoxib|Procedure: anti-cytokine therapy|Procedure: antiangiogenesis therapy|Procedure: biological therapy|Procedure: cancer prevention intervention|Procedure: chemoprevention of cancer|Procedure: enzyme inhibitor therapy|Procedure: growth factor antagonist therapyhttps://ClinicalTrials.gov/show/NCT00072540
189314189314Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: cisplatin|Drug: etoposide|Drug: irinotecan hydrochloride|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00072527
189315189315Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesCompletedNo Results AvailableAdult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell LymphDrug: gemcitabine hydrochloride|Drug: carboplatin|Drug: dexamethasone|Biological: rituximabhttps://ClinicalTrials.gov/show/NCT00072514
189316189316Breast Ultrasound and Mammography in Screening Women at High Risk for Breast CancerCompletedNo Results AvailableBreast CancerProcedure: breast imaging study|Procedure: comparison of screening methods|Procedure: magnetic resonance imaging|Procedure: radiomammography|Procedure: ultrasound imaginghttps://ClinicalTrials.gov/show/NCT00072501
189317189317Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or LymphomaActive, not recruitingNo Results AvailableLymphoma|Neuroblastoma|SarcomaProcedure: computed tomography|Procedure: magnetic resonance imaging|Procedure: positron emission tomographyhttps://ClinicalTrials.gov/show/NCT00072488
189318189318Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic SyndromesCompletedHas ResultsLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDrug: vatalanibhttps://ClinicalTrials.gov/show/NCT00072475
189319189319Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituActive, not recruitingNo Results AvailableBreast CancerDrug: tamoxifen citrate|Drug: Anastrozolehttps://ClinicalTrials.gov/show/NCT00072462
189320189320Rituximab in Treating Patients With Refractory or Relapsed Primary CNS LymphomaTerminatedHas ResultsLymphomaBiological: rituximabhttps://ClinicalTrials.gov/show/NCT00072449
189321189321Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: gemcitabine hydrochloride|Drug: alvocidib|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00072436
189322189322Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNo Results AvailableOvarian CancerRadiation: yttrium Y 90 monoclonal antibody Hu3S193https://ClinicalTrials.gov/show/NCT00072410
189323189323Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Treating Children With Intraocular RetinoblastomaCompletedNo Results AvailableIntraocular RetinoblastomaDrug: liposomal vincristine sulfate|Procedure: cryosurgery|Procedure: laser surgery|Drug: carboplatin|Drug: etoposide|Biological: filgrastimhttps://ClinicalTrials.gov/show/NCT00072384
189324189324Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaBiological: anti-GD2 murine IgG3 monoclonal antibody 3F8|Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8https://ClinicalTrials.gov/show/NCT00072358
189325189325Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Drug: lomustine|Drug: temozolomide|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00072345
189326189326Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNo Results AvailableEsophageal Cancer|Gastric Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: cisplatin|Drug: edotecarinhttps://ClinicalTrials.gov/show/NCT00072332
189327189327Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNo Results AvailableBreast CancerBiological: filgrastim|Drug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: paclitaxel|Procedure: adjuvant therapy|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00072319
189328189328Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node MicrometastasesActive, not recruitingNo Results AvailableBreast CancerProcedure: axillary lymph node dissection|Procedure: No axillary lymph node dissectionhttps://ClinicalTrials.gov/show/NCT00072293
189329189329Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood FibrosarcomaTerminatedHas ResultsSarcomaBiological: dactinomycin|Drug: cyclophosphamide|Drug: etoposide|Drug: ifosfamide|Drug: vincristine sulfate|Procedure: Conventional Surgery|Biological: MESNA (mercaptoethane sulfonate)|Biological: Filgrastimhttps://ClinicalTrials.gov/show/NCT00072280
189330189330UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: 7-hydroxystaurosporine|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00072267

* Görseller ve İçerik tekif hakkına sahip olabilir